Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F5WP
|
||||
Former ID |
DNC006053
|
||||
Drug Name |
1-(2-aminoethyl)-1H-indazol-6-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527952] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H11N3O
|
||||
Canonical SMILES |
C1=CC2=CNN(C2=CC1=O)CCN
|
||||
InChI |
1S/C9H11N3O/c10-3-4-12-9-5-8(13)2-1-7(9)6-11-12/h1-2,5-6,11H,3-4,10H2
|
||||
InChIKey |
MURPCPKOPNSCMJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527952] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527952] | ||
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527952] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.